Clinical Trial Update: Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating mitomycin C and mitoxantrone in patients with acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mitomycin-C (mitomycin C)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Leukemia | Phase 1 | Status: COMPLETED